img

Global Psychoactive Substances Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Psychoactive Substances Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Psychoactive Substances report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Psychoactive Substances market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Neuropathic Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Psychoactive Substances industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Psychoactive Substances key companies include Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc. and Alpha-CAT, etc. Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta. are top 3 players and held % share in total in 2022.
Psychoactive Substances can be divided into Stimulants, Cannabinoids, Hallucinogens and Depressants, etc. Stimulants is the mainstream product in the market, accounting for % share globally in 2022.
Psychoactive Substances is widely used in various fields, such as Cancer, Neuropathic Disorders and Spasticity,, etc. Cancer provides greatest supports to the Psychoactive Substances industry development. In 2022, global % share of Psychoactive Substances went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Psychoactive Substances market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Zynerba Pharmaceuticals
GW Pharmaceuticals PLC.
Enecta.
Teewinot Life Sciences
GD Pharma
Cape Bouvard Technologies Pty Ltd
AusCann Group Holdings Pty Ltd.
Cannabics Pharmaceuticals Inc.
Alpha-CAT
Tilray
Cyrelian Pty Ltd.
MedReleaf Australia
Segment by Type
Stimulants
Cannabinoids
Hallucinogens
Depressants

Segment by Application


Cancer
Neuropathic Disorders
Spasticity
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Psychoactive Substances market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Psychoactive Substances introduction, etc. Psychoactive Substances Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Psychoactive Substances market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Psychoactive Substances
1.1 Psychoactive Substances Market Overview
1.1.1 Psychoactive Substances Product Scope
1.1.2 Psychoactive Substances Market Status and Outlook
1.2 Global Psychoactive Substances Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Psychoactive Substances Market Size by Region (2024-2034)
1.4 Global Psychoactive Substances Historic Market Size by Region (2024-2024)
1.5 Global Psychoactive Substances Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Psychoactive Substances Market Size (2024-2034)
1.6.1 North America Psychoactive Substances Market Size (2024-2034)
1.6.2 Europe Psychoactive Substances Market Size (2024-2034)
1.6.3 Asia-Pacific Psychoactive Substances Market Size (2024-2034)
1.6.4 Latin America Psychoactive Substances Market Size (2024-2034)
1.6.5 Middle East & Africa Psychoactive Substances Market Size (2024-2034)
2 Psychoactive Substances Market by Type
2.1 Introduction
2.1.1 Stimulants
2.1.2 Cannabinoids
2.1.3 Hallucinogens
2.1.4 Depressants
2.2 Global Psychoactive Substances Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Psychoactive Substances Historic Market Size by Type (2024-2024)
2.2.2 Global Psychoactive Substances Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Psychoactive Substances Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Psychoactive Substances Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Psychoactive Substances Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Psychoactive Substances Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Psychoactive Substances Revenue Breakdown by Type (2024-2034)
3 Psychoactive Substances Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Neuropathic Disorders
3.1.3 Spasticity
3.2 Global Psychoactive Substances Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Psychoactive Substances Historic Market Size by Application (2024-2024)
3.2.2 Global Psychoactive Substances Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Psychoactive Substances Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Psychoactive Substances Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Psychoactive Substances Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Psychoactive Substances Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Psychoactive Substances Revenue Breakdown by Application (2024-2034)
4 Psychoactive Substances Competition Analysis by Players
4.1 Global Psychoactive Substances Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
4.3 Date of Key Players Enter into Psychoactive Substances Market
4.4 Global Top Players Psychoactive Substances Headquarters and Area Served
4.5 Key Players Psychoactive Substances Product Solution and Service
4.6 Competitive Status
4.6.1 Psychoactive Substances Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zynerba Pharmaceuticals
5.1.1 Zynerba Pharmaceuticals Profile
5.1.2 Zynerba Pharmaceuticals Main Business
5.1.3 Zynerba Pharmaceuticals Psychoactive Substances Products, Services and Solutions
5.1.4 Zynerba Pharmaceuticals Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.1.5 Zynerba Pharmaceuticals Recent Developments
5.2 GW Pharmaceuticals PLC.
5.2.1 GW Pharmaceuticals PLC. Profile
5.2.2 GW Pharmaceuticals PLC. Main Business
5.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Products, Services and Solutions
5.2.4 GW Pharmaceuticals PLC. Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.2.5 GW Pharmaceuticals PLC. Recent Developments
5.3 Enecta.
5.3.1 Enecta. Profile
5.3.2 Enecta. Main Business
5.3.3 Enecta. Psychoactive Substances Products, Services and Solutions
5.3.4 Enecta. Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.3.5 Teewinot Life Sciences Recent Developments
5.4 Teewinot Life Sciences
5.4.1 Teewinot Life Sciences Profile
5.4.2 Teewinot Life Sciences Main Business
5.4.3 Teewinot Life Sciences Psychoactive Substances Products, Services and Solutions
5.4.4 Teewinot Life Sciences Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.4.5 Teewinot Life Sciences Recent Developments
5.5 GD Pharma
5.5.1 GD Pharma Profile
5.5.2 GD Pharma Main Business
5.5.3 GD Pharma Psychoactive Substances Products, Services and Solutions
5.5.4 GD Pharma Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.5.5 GD Pharma Recent Developments
5.6 Cape Bouvard Technologies Pty Ltd
5.6.1 Cape Bouvard Technologies Pty Ltd Profile
5.6.2 Cape Bouvard Technologies Pty Ltd Main Business
5.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Products, Services and Solutions
5.6.4 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.6.5 Cape Bouvard Technologies Pty Ltd Recent Developments
5.7 AusCann Group Holdings Pty Ltd.
5.7.1 AusCann Group Holdings Pty Ltd. Profile
5.7.2 AusCann Group Holdings Pty Ltd. Main Business
5.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Products, Services and Solutions
5.7.4 AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.7.5 AusCann Group Holdings Pty Ltd. Recent Developments
5.8 Cannabics Pharmaceuticals Inc.
5.8.1 Cannabics Pharmaceuticals Inc. Profile
5.8.2 Cannabics Pharmaceuticals Inc. Main Business
5.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Products, Services and Solutions
5.8.4 Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.8.5 Cannabics Pharmaceuticals Inc. Recent Developments
5.9 Alpha-CAT
5.9.1 Alpha-CAT Profile
5.9.2 Alpha-CAT Main Business
5.9.3 Alpha-CAT Psychoactive Substances Products, Services and Solutions
5.9.4 Alpha-CAT Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.9.5 Alpha-CAT Recent Developments
5.10 Tilray
5.10.1 Tilray Profile
5.10.2 Tilray Main Business
5.10.3 Tilray Psychoactive Substances Products, Services and Solutions
5.10.4 Tilray Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.10.5 Tilray Recent Developments
5.11 Cyrelian Pty Ltd.
5.11.1 Cyrelian Pty Ltd. Profile
5.11.2 Cyrelian Pty Ltd. Main Business
5.11.3 Cyrelian Pty Ltd. Psychoactive Substances Products, Services and Solutions
5.11.4 Cyrelian Pty Ltd. Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.11.5 Cyrelian Pty Ltd. Recent Developments
5.12 MedReleaf Australia
5.12.1 MedReleaf Australia Profile
5.12.2 MedReleaf Australia Main Business
5.12.3 MedReleaf Australia Psychoactive Substances Products, Services and Solutions
5.12.4 MedReleaf Australia Psychoactive Substances Revenue (US$ Million) & (2024-2024)
5.12.5 MedReleaf Australia Recent Developments
6 North America
6.1 North America Psychoactive Substances Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Psychoactive Substances Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Psychoactive Substances Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Psychoactive Substances Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Psychoactive Substances Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Psychoactive Substances Market Dynamics
11.1 Psychoactive Substances Industry Trends
11.2 Psychoactive Substances Market Drivers
11.3 Psychoactive Substances Market Challenges
11.4 Psychoactive Substances Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Psychoactive Substances Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Psychoactive Substances Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Psychoactive Substances Market Size Share by Region (2024-2024)
Table 4. Global Psychoactive Substances Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Psychoactive Substances Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Psychoactive Substances Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Psychoactive Substances Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Psychoactive Substances Revenue Market Share by Type (2024-2024)
Table 9. Global Psychoactive Substances Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Psychoactive Substances Revenue Market Share by Type (2024-2034)
Table 11. North America Psychoactive Substances Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Psychoactive Substances Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Psychoactive Substances Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Psychoactive Substances Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Psychoactive Substances Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Psychoactive Substances Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Psychoactive Substances Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Psychoactive Substances Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Psychoactive Substances Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Psychoactive Substances Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Psychoactive Substances Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Psychoactive Substances Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Psychoactive Substances Revenue Market Share by Application (2024-2024)
Table 24. Global Psychoactive Substances Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Psychoactive Substances Revenue Market Share by Application (2024-2034)
Table 26. North America Psychoactive Substances Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Psychoactive Substances Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Psychoactive Substances Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Psychoactive Substances Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Psychoactive Substances Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Psychoactive Substances Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Psychoactive Substances Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Psychoactive Substances Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Psychoactive Substances Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Psychoactive Substances Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Psychoactive Substances Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Psychoactive Substances Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
Table 39. Date of Key Players Enter into Psychoactive Substances Market
Table 40. Global Psychoactive Substances Key Players Headquarters and Area Served
Table 41. Psychoactive Substances Product Solution and Service
Table 42. Global Psychoactive Substances Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Zynerba Pharmaceuticals Basic Information List
Table 45. Zynerba Pharmaceuticals Description and Business Overview
Table 46. Zynerba Pharmaceuticals Psychoactive Substances Products, Services and Solutions
Table 47. Revenue (US$ Million) in Psychoactive Substances Business of Zynerba Pharmaceuticals (2024-2024)
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals PLC. Basic Information List
Table 50. GW Pharmaceuticals PLC. Description and Business Overview
Table 51. GW Pharmaceuticals PLC. Psychoactive Substances Products, Services and Solutions
Table 52. Revenue (US$ Million) in Psychoactive Substances Business of GW Pharmaceuticals PLC. (2024-2024)
Table 53. GW Pharmaceuticals PLC. Recent Developments
Table 54. Enecta. Basic Information List
Table 55. Enecta. Description and Business Overview
Table 56. Enecta. Psychoactive Substances Products, Services and Solutions
Table 57. Revenue (US$ Million) in Psychoactive Substances Business of Enecta. (2024-2024)
Table 58. Enecta. Recent Developments
Table 59. Teewinot Life Sciences Basic Information List
Table 60. Teewinot Life Sciences Description and Business Overview
Table 61. Teewinot Life Sciences Psychoactive Substances Products, Services and Solutions
Table 62. Revenue (US$ Million) in Psychoactive Substances Business of Teewinot Life Sciences (2024-2024)
Table 63. Teewinot Life Sciences Recent Developments
Table 64. GD Pharma Basic Information List
Table 65. GD Pharma Description and Business Overview
Table 66. GD Pharma Psychoactive Substances Products, Services and Solutions
Table 67. Revenue (US$ Million) in Psychoactive Substances Business of GD Pharma (2024-2024)
Table 68. GD Pharma Recent Developments
Table 69. Cape Bouvard Technologies Pty Ltd Basic Information List
Table 70. Cape Bouvard Technologies Pty Ltd Description and Business Overview
Table 71. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Products, Services and Solutions
Table 72. Revenue (US$ Million) in Psychoactive Substances Business of Cape Bouvard Technologies Pty Ltd (2024-2024)
Table 73. Cape Bouvard Technologies Pty Ltd Recent Developments
Table 74. AusCann Group Holdings Pty Ltd. Basic Information List
Table 75. AusCann Group Holdings Pty Ltd. Description and Business Overview
Table 76. AusCann Group Holdings Pty Ltd. Psychoactive Substances Products, Services and Solutions
Table 77. Revenue (US$ Million) in Psychoactive Substances Business of AusCann Group Holdings Pty Ltd. (2024-2024)
Table 78. AusCann Group Holdings Pty Ltd. Recent Developments
Table 79. Cannabics Pharmaceuticals Inc. Basic Information List
Table 80. Cannabics Pharmaceuticals Inc. Description and Business Overview
Table 81. Cannabics Pharmaceuticals Inc. Psychoactive Substances Products, Services and Solutions
Table 82. Revenue (US$ Million) in Psychoactive Substances Business of Cannabics Pharmaceuticals Inc. (2024-2024)
Table 83. Cannabics Pharmaceuticals Inc. Recent Developments
Table 84. Alpha-CAT Basic Information List
Table 85. Alpha-CAT Description and Business Overview
Table 86. Alpha-CAT Psychoactive Substances Products, Services and Solutions
Table 87. Revenue (US$ Million) in Psychoactive Substances Business of Alpha-CAT (2024-2024)
Table 88. Alpha-CAT Recent Developments
Table 89. Tilray Basic Information List
Table 90. Tilray Description and Business Overview
Table 91. Tilray Psychoactive Substances Products, Services and Solutions
Table 92. Revenue (US$ Million) in Psychoactive Substances Business of Tilray (2024-2024)
Table 93. Tilray Recent Developments
Table 94. Cyrelian Pty Ltd. Basic Information List
Table 95. Cyrelian Pty Ltd. Description and Business Overview
Table 96. Cyrelian Pty Ltd. Psychoactive Substances Products, Services and Solutions
Table 97. Revenue (US$ Million) in Psychoactive Substances Business of Cyrelian Pty Ltd. (2024-2024)
Table 98. Cyrelian Pty Ltd. Recent Developments
Table 99. MedReleaf Australia Basic Information List
Table 100. MedReleaf Australia Description and Business Overview
Table 101. MedReleaf Australia Psychoactive Substances Products, Services and Solutions
Table 102. Revenue (US$ Million) in Psychoactive Substances Business of MedReleaf Australia (2024-2024)
Table 103. MedReleaf Australia Recent Developments
Table 104. North America Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 105. North America Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 106. Europe Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 107. Europe Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 108. Asia-Pacific Psychoactive Substances Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 109. Asia-Pacific Psychoactive Substances Market Size by Region (2024-2024) & (US$ Million)
Table 110. Asia-Pacific Psychoactive Substances Market Size by Region (2024-2034) & (US$ Million)
Table 111. Asia-Pacific Psychoactive Substances Market Share by Region (2024-2024)
Table 112. Asia-Pacific Psychoactive Substances Market Share by Region (2024-2034)
Table 113. Latin America Psychoactive Substances Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Latin America Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 115. Latin America Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 116. Middle East & Africa Psychoactive Substances Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 117. Middle East & Africa Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 118. Middle East & Africa Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 119. Psychoactive Substances Market Trends
Table 120. Psychoactive Substances Market Drivers
Table 121. Psychoactive Substances Market Challenges
Table 122. Psychoactive Substances Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychoactive Substances Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Psychoactive Substances Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Psychoactive Substances Market Share by Regions: 2022 VS 2034
Figure 4. Global Psychoactive Substances Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Psychoactive Substances Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Psychoactive Substances Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Psychoactive Substances Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Psychoactive Substances Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Psychoactive Substances Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Stimulants
Figure 11. Global Stimulants Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Cannabinoids
Figure 13. Global Cannabinoids Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Hallucinogens
Figure 15. Global Hallucinogens Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Depressants
Figure 17. Global Depressants Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Psychoactive Substances Market Size Share by Type: 2022 & 2034
Figure 19. North America Psychoactive Substances Revenue Market Share by Type (2024-2034)
Figure 20. Europe Psychoactive Substances Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Psychoactive Substances Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Psychoactive Substances Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Psychoactive Substances Revenue Market Share by Type (2024-2034)
Figure 24. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Neuropathic Disorders Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Spasticity Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Global Psychoactive Substances Market Size Share by Application: 2022 & 2034
Figure 28. North America Psychoactive Substances Revenue Market Share by Application (2024-2034)
Figure 29. Europe Psychoactive Substances Revenue Market Share by Application (2024-2034)
Figure 30. Asia-Pacific Psychoactive Substances Revenue Market Share by Application (2024-2034)
Figure 31. Latin America Psychoactive Substances Revenue Market Share by Application (2024-2034)
Figure 32. Middle East and Africa Psychoactive Substances Revenue Market Share by Application (2024-2034)
Figure 33. Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 34. Global Top 5 and Top 10 Players Psychoactive Substances Market Share in 2022
Figure 35. North America Psychoactive Substances Market Share by Country (2024-2034)
Figure 36. United States Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 37. Canada Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 38. Germany Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 39. France Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 40. U.K. Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 41. Italy Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 42. Russia Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 43. Nordic Countries Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 44. Asia-Pacific Psychoactive Substances Market Share by Region (2024-2034)
Figure 45. China Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 46. Japan Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 47. South Korea Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 48. Southeast Asia Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 49. India Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 50. Australia Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 51. Latin America Psychoactive Substances Market Share by Country (2024-2034)
Figure 52. Mexico Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 53. Brazil Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 54. Middle East & Africa Psychoactive Substances Market Share by Country (2024-2034)
Figure 55. Turkey Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 56. Saudi Arabia Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 57. UAE Psychoactive Substances Market Size (2024-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries